Scenarios that move ONC

BeOne Medicines Ltd. - American Depositary Shares

Scenarios that move ONC: 3 analyses, 2 positive, 1 negative.

  1. · Genmab and AbbVie report positive epcoritamab lymphoma trial results — ▼ · impact -15 · confidence low · horizon quarters
  2. · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▲ · impact +22 · confidence low · horizon weeks
  3. · Zymeworks updates 2026 guidance after Theravance acquisition — ▲ · impact +10 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing